OFFICIAL PUBLICATION OF

by its subsidiary APPco

ACCC vs Pfizer case comes to a close

Sheshtyn Paola 26/10/2018

The High Court has dismissed the ACCC’s application for special leave to appeal in its case against Pfizer Australia over the sale of atorvastatin This month the Australian Competition and Consumer Commission (ACCC) sought leave to appeal against a judgment handed down by the Full Federal Court on 25 May 2018, following a longstanding case

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Recent Comments
Popular Posts

Teal questions pharmacist UTI programs

because much of the time, I think they’re giving antibiotics for things that are not UTIsPolitician says "I think" and…

Michael Hewson

Medics to ‘fight’ Doctor of Pharmacy title

Yet right now there are far too many reports from overseas of patients being unsure whether their care is from…

Michael Hewson

In scarce supply

I love a good joke.

Evan Nickols

Concurrent funding for aged care pharmacists and RMMRs needed

I understood that was to happen as a gradual changeover and not an abrupt cessation. Currently we do not have…

Jenny Gowan

ACCC vs Pfizer case comes to a close

Previous A matter of life and death

Next 5 hidden pitfalls in ‘standard’ franchise agreements

Ceramides: what are they and why are they important?

In the beginning

The signs of ageing

Hyperpigmentation

MENU

Previous A matter of life and death

Next 5 hidden pitfalls in ‘standard’ franchise agreements

Related Posts

MENU

Hi there! 👋 Looks like you’re not logged in.